Maria Cristina Pirosa

Genetic and phenotypic attributes of splenic marginal zone lymphoma

Ferdinando Bonfiglio, Alessio Bruscaggin, Francesca Guidetti et al. · Blood · 2021 · 97 citations · Full text

Medicine, Genetics, Pathology +17

SAKK38/07 study: integration of baseline metabolic heterogeneity and metabolic tumor volume in DLBCL prognostic model

Luca Ceriani, Giuseppe Gritti, Luciano Cascione et al. · Blood Advances · 2020 · 75 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

PMN-MDSC and arginase are increased in myeloma and may contribute to resistance to therapy

Alessandra Romano, Nunziatina Laura Parrinello, Piera La Cava et al. · Expert Review of Molecular Diagnostics · 2018 · 70 citations

Medicine, Hematology, Pharmacology +17

Prognostic value of POD24 validation in follicular lymphoma patients initially treated with chemotherapy‐free regimens in a pooled analysis of three randomized trials of the Swiss Group for Clinical Cancer Research (SAKK)

Alden A. Moccia, Sämi Schär, Stefanie Hayoz et al. · British Journal of Haematology · 2020 · 33 citations · Full text

Medicine, Immunology, Oncology +17

IELSG30 phase 2 trial: intravenous and intrathecal CNS prophylaxis in primary testicular diffuse large B-cell lymphoma

Annarita Conconi, Annalisa Chiappella, Andrés J.M. Ferreri et al. · Blood Advances · 2024 · 29 citations · Full text

Medicine, Oncology, Pharmacotherapy +17